• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

bcr基因内断点的位置是费城染色体阳性慢性粒细胞白血病患者的一个预后因素。

The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients.

作者信息

Mills K I, MacKenzie E D, Birnie G D

机构信息

Beatson Institute for Cancer Research, Glasgow, Scotland.

出版信息

Blood. 1988 Oct;72(4):1237-41.

PMID:3167206
Abstract

The Philadelphia (Ph1) chromosome, characteristic of chronic myelogenous leukemia (CML), arises from a reciprocal translocation between chromosomes 9 and 22. The site of the breakpoint on chromosome 22 is within a small region called the breakpoint cluster region (bcr). We have mapped the breakpoint within the bcr in peripheral blood leukocyte DNA from 22 Ph1-positive CML patients. No correlation between the site of the breakpoint and the clinical phase of the disease was found. However, a striking correlation between the site of the breakpoint and the length of time between presentation and onset of acute phase was observed: on average, patients with a 5' break-point had a fourfold longer chronic phase (median, 203 weeks) than those with a 3' breakpoint (median, 52 weeks).

摘要

费城(Ph1)染色体是慢性粒细胞白血病(CML)的特征性染色体,它由9号和22号染色体之间的相互易位产生。22号染色体上的断点位于一个称为断点簇区域(bcr)的小区域内。我们已经绘制了22例Ph1阳性CML患者外周血白细胞DNA中bcr内的断点图谱。未发现断点位置与疾病临床分期之间存在相关性。然而,观察到断点位置与出现症状至急性期发作之间的时间长度存在显著相关性:平均而言,5' 断点的患者慢性期(中位数为203周)比3' 断点的患者(中位数为52周)长四倍。

相似文献

1
The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients.bcr基因内断点的位置是费城染色体阳性慢性粒细胞白血病患者的一个预后因素。
Blood. 1988 Oct;72(4):1237-41.
2
No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.在Ph1阳性慢性粒细胞白血病患者中,bcr断点位置与临床状态之间无相关性。
Leukemia. 1989 Jul;3(7):492-6.
3
Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.用于慢性粒细胞白血病中费城(Ph1)染色体易位的DNA探针检测法的临床评估
Leukemia. 1988 Oct;2(10):648-57.
4
Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.慢性髓性白血病(CML)中一种变异的费城染色体1易位t(9;22;11) (q34;q11;q13)的分子特征显示,BCR基因的3'端部分易位至染色体带11q13。 1 费城染色体(Philadelphia chromosome,Ph)是一种特异性染色体异常,在慢性髓性白血病中常见。
Oncogene. 1993 Dec;8(12):3239-47.
5
The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.费城染色体阳性慢性髓性白血病患者的断点簇集区位点。临床、实验室及预后相关性
Cancer. 1995 Sep 15;76(6):992-7. doi: 10.1002/1097-0142(19950915)76:6<992::aid-cncr2820760612>3.0.co;2-l.
6
Location of breakpoints within the major breakpoint cluster region (bcr) in 33 patients with bcr rearrangement-positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes.33例伴有复杂或缺失费城染色体且bcr重排阳性的慢性髓性白血病(CML)患者中主要断裂点簇区域(bcr)内断点的定位。
Genes Chromosomes Cancer. 1989 Sep;1(1):106-11. doi: 10.1002/gcc.2870010116.
7
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.伴有断裂点簇集区重排的费城染色体阴性慢性粒细胞白血病。长期随访结果。
Cancer. 1995 Jan 15;75(2):464-70. doi: 10.1002/1097-0142(19950115)75:2<464::aid-cncr2820750209>3.0.co;2-e.
8
Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
Cancer Genet Cytogenet. 1996 Jul 15;89(2):153-6. doi: 10.1016/0165-4608(96)00021-0.
9
Distribution of breakpoint within the breakpoint cluster region (bcr) in chronic myelogenous leukemia with a complex Philadelphia chromosome translocation.具有复杂费城染色体易位的慢性髓性白血病中,断点在断点簇区域(bcr)内的分布情况。
Am J Hematol. 1989 Nov;32(3):194-9. doi: 10.1002/ajh.2830320307.
10
Translocation t(9;9)(p13;q34) in Philadelphia-negative chronic myeloid leukemia with breakpoint cluster region rearrangement.
Cancer Genet Cytogenet. 1989 Nov;43(1):51-6. doi: 10.1016/0165-4608(89)90126-x.

引用本文的文献

1
Measurable residual disease in chronic myeloid leukemia.慢性髓性白血病的可测量残留病。
Haematologica. 2022 Dec 1;107(12):2794-2809. doi: 10.3324/haematol.2022.281493.
2
Prognostic Significance of Transcript-Type in Chronic Myeloid Leukemia.转录本类型在慢性髓性白血病中的预后意义
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020062. doi: 10.4084/MJHID.2020.062. eCollection 2020.
3
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview.慢性髓性白血病中不同 BCR-ABL1 转录本类型的比例。国际概述。
Leukemia. 2019 May;33(5):1173-1183. doi: 10.1038/s41375-018-0341-4. Epub 2019 Jan 23.
4
Bone marrow transplantation. Part I--Allogeneic.骨髓移植。第一部分——同种异体移植。
West J Med. 1989 Dec;151(6):638-43.
5
Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.22号染色体断点簇区域(bcr)内断点的精细定位表明bcr外显子3在决定慢性粒细胞白血病疾病持续时间中起作用。
Am J Hum Genet. 1989 Nov;45(5):729-38.
6
A study of the myeloid differentiation antigens of the peripheral blood neutrophil granulocytes in the different evolutive phases of chronic myeloid leukemia.慢性髓系白血病不同演变阶段外周血中性粒细胞髓系分化抗原的研究
Ann Hematol. 1991 Jun;62(6):221-4. doi: 10.1007/BF01729836.
7
Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: the value of early evaluation of the course of the disease. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.
Ann Hematol. 1991 Dec;63(6):307-14. doi: 10.1007/BF01709652.